Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,101.9
9.8 (0.32%)

 

  • STI Straits Times Index
    3,101.9
    9.8 (0.32%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,501.7
    4.8 (0.32%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,766.7
    -22.2 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,607.4
    33.6 (0.94%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 818.5M
  • Value: 1,115.1M
  • Rise: 182
  • Fall: 131
  • Unch: 448

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.083-
Genting Sing0.760+0.015
SingHaiyi0.117-
CapLand IntCom T2.060-0.010
Singtel2.380-
Metal Component0.047-0.003
HGH0.019-
Golden Agri-Res0.235+0.010
HPH Trust USD0.230+0.005
Mapletree Log Tr1.870-

World Indices

World Indices
Name Last Change
Nasdaq 15,537.7 -245.1
HSI 23,766.7 -22.2
HSCEI 8,455.5 -50.9
Jakarta 6,538.5 -45.3
Nikkei 225 27,935.6
SSE Comp 3,607.4 +33.6
Shanghai A 3,781.0 +35.2
Shanghai B 286.0 +2.9
KOSPI 2,968.3 +23.1

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

QUIDEL CORP QUIDEL CORP
Updated on 03 Dec 2021 (End of trading day)
Last (USD): 147.950 Change: +1.450 High: 150.185 Remarks: -
Change (%): +0.99 Low: 143.005

Company Background

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a 19.44314 Trailing EPS (USD) b 21.18885 NAV (USD) c 39.2100
PE a 7.609 Trailing PE d 6.982 Price / NAV c 3.7733
Dividend Yield (%) e - Cash In Hand (USD) f 13.8801 Issued & Paid-up Shares g 41,674,700
Piotroski F Score 7 Market Cap (M) 6,165.772 Free Float (%) 87.9
Return on Equity (ROE) (%) h 54.039 Revenue Growth (%) TTM i 86.224
Net Earnings Growth (%) j 138.155 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 10 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+3.140
+2.17 %
10 Days --4.550
-2.98 %
20 Days -+26.850
+22.17 %
Medium Term Return 3 Months -+6.060
+4.27 %
6 Months -+43.880
+42.16 %
1 Year --45.620
-23.57 %
Long Term Return 2 Years -+77.020
+108.59 %
3 Years -+99.220
+203.61 %
5 Years -+124.910
+542.14 %
Annualised Return Annualised --
+45.05 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QUIDEL CORP NASDAQ 6,165.772 7.609 6.982 3.7733 -
Industry Medical Specialties NASDAQ 2,973.653 128.783 131.538 8.2337 0.026
Local Peer INTUITIVE SURGICAL INC NASDAQ 114,812.904 108.253 67.969 10.0617 -
Local Peer DEXCOM INC NASDAQ 50,350.010 102.006 95.126 23.5710 -
Local Peer IDEXX LABORATORIES INC NASDAQ 49,734.838 85.488 65.712 65.8952 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 48,869.209 27.518 66.035 13.8961 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 24,415.198 33.556 52.934 7.3597 -
Local Peer INSULET CORPORATION NASDAQ 18,150.124 2,669.067 - 36.4532 -
Local Peer HOLOGIC INC NASDAQ 18,590.069 9.933 9.933 4.4067 -
Local Peer MASIMO CORPORATION NASDAQ 15,294.754 63.648 65.909 10.4177 -
Local Peer ABIOMED INC NASDAQ 13,677.643 60.648 91.703 9.8787 -
Local Peer BRUKER CORPORATION NASDAQ 11,986.811 75.962 44.346 11.1443 0.203
Local Peer DENTSPLY SIRONA INC NASDAQ 11,087.747 - 26.557 2.1647 0.789
Local Peer NOVOCURE LTD NASDAQ 8,519.387 430.106 - 20.6196 -
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INMODE LTD (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), CAREDX INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CUE HEALTH INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), BIOVENTUS INC (NASDAQ), VIEWRAY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), NATUS MEDICAL INC (NASDAQ), INTERCURE LTD (NASDAQ), INOGEN INC (NASDAQ), 908 DEVICES INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), SI BONE INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), IRADIMED CORP (NASDAQ), DERMTECH INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYXOAH SA (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), AXOGEN INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AVITA MEDICAL INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), PAVMED INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), LUCIRA HEALTH INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), NEUROPACE INC (NASDAQ), QUOTIENT LTD (NASDAQ), CVRX INC (NASDAQ), SIENTRA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), ONCOCYTE CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), EARGO INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TELA BIO INC (NASDAQ), MINERVA SURGICAL INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), CONFORMIS INC (NASDAQ), INTRICOM CORP (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), FONAR CORP (NASDAQ), NEURONETICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), IRIDEX CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), LENSAR INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), NEPHROS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CELSION CORPORATION (NASDAQ), ENVVENO MED CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), AVINGER INC (NASDAQ), ELECTROCORE INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NUTRIBAND INC (NASDAQ), NEUROMETRIX INC (NASDAQ), NEOVASC INC (NASDAQ), APPLIED UV INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), AETHLON MEDICAL INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), HEARTBEAM INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), INSPIREMD INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 250,657.873 39.319 29.265 6.4753 0.139
Global Peer ABBOTT LABORATORIES NYSE 230,355.138 51.499 31.941 6.6921 1.176
Global Peer DANAHER CORP NYSE 223,619.726 63.709 39.081 5.5650 0.229
Global Peer MEDTRONIC PLC NYSE 143,725.188 39.857 30.547 2.7644 2.265
Global Peer STRYKER CORP NYSE 93,129.239 58.242 49.015 6.5686 0.951
Global Peer BECTON DICKINSON & CO NYSE 69,335.939 34.633 34.633 2.9287 1.379
Global Peer EDWARDS LIFESCIENCES CORP NYSE 67,727.752 82.253 45.846 12.2224 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 56,230.105 - 53.964 3.4157 -